In a recent review of the market’s current conditions, JPMorgan strategist Eduardo Lecubarri recaps his view that 2021 will see modest gains across …
Arguably the most controversial on the Street, penny stocks are a hot-button issue. Usually, there isn’t a lot of middle-ground with respect to …
Reports of raw materials shortages causing production delays for Novavax’s (NVAX) COVID-19 vaccine forced the company to postpone signing a supply contract with …
Quant trading guru Jim Simons is calling it a day, sort of. The mathematician and cryptologist is famous in the investing world for …
The stock markets have been on a roller-coaster ride in recent sessions. However, while volatility is ruling for now, some market watchers see …
Risk and reward are the yin and yang of stock trading, the two opposite but essential ingredients in every market success. And there …
Bank of America has a strong reputation for keeping finger on the pulse of the financial world – and one of its key …
Is a pause to the stock market’s continued surge finally in the cards? The talk has turned to rising interest rates and the …
The new coronavirus mutant strains are playing havoc with the already approved Covid-19 vaccines. The latest data shows AstraZeneca’s (AZN) vaccine, AZD1222 is …
Let’s talk about risk and the big picture. It’s an appropriate time, as the big risk – presented by the COVID-19 pandemic – …
